COMMUNIQUÉS West-GlobeNewswire

-
Tetra Bio-Pharma Files Patent Application to Protect PPP001
28/01/2019 -
111, Inc. to Collaborate with Lilly in Creating New Solutions for Pharmaceutical Distribution
28/01/2019 -
Evelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic Melanoma
28/01/2019 -
Arrayit Corporation Allergy Testing Services Endorsed by Leading Pediatrics Medical Group
28/01/2019 -
Novo Nordisk A/S: Share repurchase programme
28/01/2019 -
Unilever and Bio-on present My Kai the new line of ultra-green sun creams
28/01/2019 -
Nicox Establishes High-Profile Glaucoma Clinical Advisory Board
28/01/2019 -
Nicox constitue un Comité consultatif clinique d'experts sur le glaucome
28/01/2019 -
Biocartis Group NV: Disclosure of a transparency notification
28/01/2019 -
EDITORIAL ON POSITIVE DATA FOR BARHEMSYS™ RESCUE TREATMENT OF POST-OPERATIVE NAUSEA & VOMITING (PONV) PUBLISHED IN ANESTHESIOLOGY
28/01/2019 -
Genmab Announces that the patents asserted against DARZALEX® in the United States have been declared invalid by summary judgment.
26/01/2019 -
Bellerophon Announces Closing of $7 Million Public Offering of Common Stock
25/01/2019 -
New York Stock Exchange Accepts Milestone Scientific’s Plan to Regain Compliance
25/01/2019 -
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
25/01/2019 -
Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Thursday, February 28, 2019
25/01/2019 -
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
25/01/2019 -
N.M. Medical Cannabis Program Finishes 2018 With $106 Million in Sales
25/01/2019 -
Dr. Amir Bajoghli has been chosen as president of the Medical Society of Northern Virginia
25/01/2019 -
MacroGenics Announces Removal of Partial Clinical Hold on MGD009 Program by FDA
25/01/2019
Pages